MSMDL-DDI: Multi-Layer Soft Mask Dual-View Learning for Drug–Drug Interactions
- 23 January 2025
- journal article
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 115, 108355
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Development and validation of a machine learning model for predicting drug-drug interactions with oral diabetes medicationsMethods, 2024
- DAS-DDI: A dual-view framework with drug association and drug structure for drug–drug interaction predictionJournal of Biomedical Informatics, 2024
- MGDDI: A multi-scale graph neural networks for drug–drug interaction predictionMethods, 2024
- Health insurance fraud detection based on multi-channel heterogeneous graph structure learningHeliyon, 2024
- Deep learning for drug‐drug interaction prediction: A comprehensive reviewQuantitative Biology, 2024
- SRR-DDI: A drug–drug interaction prediction model with substructure refined representation learning based on self-attention mechanismKnowledge-Based Systems, 2023
- MATT-DDI: Predicting multi-type drug-drug interactions via heterogeneous attention mechanismsMethods, 2023
- MM-GANN-DDI: Multimodal Graph-Agnostic Neural Networks for Predicting Drug–Drug Interaction EventsComputers in Biology and Medicine, 2023
- Improved prediction of drug-drug interactions using ensemble deep neural networksMedicine in Drug Discovery, 2022
- Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug developmentDrug Discovery Today, 2005